BILLERICA, Mass. & PHILADELPHIA--(BUSINESS WIRE)--Millipore Corporation (NYSE: MIL) and Rohm and Haas Company (NYSE: ROH) today announced a joint development agreement to create new high-performance chromatography products that are used to manufacture biologic drugs. The strength of this partnership lies in combining Millipore’s biopharmaceutical manufacturing expertise with Rohm and Haas’ knowledge of ion exchange resins, polymer chemistry and manufacturing.
